MALDI Oligonucleotide Analysis for Fast Impurity Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for analyzing oligonucleotides, particularly for pharmaceutical applications, face challenges in efficiently detecting impurities such as incompletely elongated oligonucleotides, incomplete fragments, and stereoisomers due to high workload and time-consuming separation processes, especially with HPLC and LC-MS.

Innovation Solution

Perform MALDI mass spectrometry using a predetermined matrix, such as an acetophenone-based compound, and set a laser intensity to suppress in-source decay, allowing easy detection of impurities in oligonucleotides.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If HPLC or LC-MS is used to analyze oligonucleotide reaction mixtures, then separation and detection of components can be achieved, but analysis time is long and throughput is low

Engineering Contradiction:
Improvedetection capabilityVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces the mechanical separation system (HPLC columns, pumps, flow cells) with a mass spectrometry-based detection system. MALDI-TOF MS directly ionizes and detects oligonucleotide molecules based on their mass-to-charge ratio, eliminating the need for prolonged chromatographic separation while maintaining detection capability for various oligonucleotide components including impurities.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the detection parameter from chromatographic retention time to mass-to-charge ratio. By using MALDI-TOF MS, the analysis shifts from separating components based on their interaction with stationary phases to detecting components based on their intrinsic mass properties, significantly reducing analysis time while preserving detection precision.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If multiple separation modes are used to detect different types of impurities (stereoisomers, incomplete fragments), then detection coverage is improved, but workload and operational complexity increase

Engineering Contradiction:
Improvedetection coverageVSAvoidworkload
Core Design Contradiction:
Adaptability or versatilityVSEase of operation

Solution Approach 1:

The patent implements a universal detection approach using MALDI-TOF mass spectrometry that can detect all types of oligonucleotide impurities (incomplete fragments, stereoisomers, modified forms) through a single analysis method. The mass spectrometer detects all ions in the sample based on their mass-to-charge ratio, eliminating the need to switch between different separation modes and reducing operational workload.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent changes from multiple separation parameters (different mobile phases, column types, temperature conditions) to a single mass-to-charge ratio parameter. This single parameter approach provides comprehensive detection coverage for all impurity types while simplifying the operational procedure to a single, standardized analysis method.

Inventive Principle:
Principle #35Parameter changes

3Power

If conventional MALDI mass spectrometry is used with high laser intensity, then ionization efficiency is improved, but in-source decay occurs reducing detection accuracy

Engineering Contradiction:
Improveionization efficiencyVSAvoiddetection accuracy
Core Design Contradiction:
PowerVSMeasurement precision

Solution Approach 1:

The patent optimizes the laser intensity parameter to a specific range that balances ionization efficiency and in-source decay suppression. By carefully controlling the laser power setting, the method achieves sufficient ionization for sensitive detection while preventing excessive energy input that would cause molecular fragmentation and reduce measurement precision.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs dynamic control of laser intensity, adjusting the power level based on sample characteristics and detection requirements. This dynamic parameter optimization allows the system to adapt to different oligonucleotide samples while maintaining the optimal balance between ionization efficiency and prevention of in-source decay.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables efficient detection of impurities in oligonucleotides, reducing analysis time and workload, and improving detection sensitivity and accuracy.

Implementation Method 1

an acquisition step of performing mass spectrometry by irradiating the sample applied to the plate with a laser beam in a MALDI mass spectrometer

Methodology Applied
Scientific EffectLaser irradiation: Laser

Implementation Method 2

performing mass spectrometry by irradiating the sample applied to the plate with a laser beam in a MALDI mass spectrometer

Methodology Applied
Scientific EffectIonization: Ionisation

Implementation Method 3

the matrix includes an acetophenone-based compound

Methodology Applied
Scientific EffectMatrix-assisted laser desorption/ionization:

Data Source

PatentEP4703720A1Oligonucleotide analysis method
Publication Date: 2026.03.04 SHIMADZU CORP
  • EP4703720A1 patent drawingFigure 1
  • EP4703720A1 patent drawingFigure 2
  • EP4703720A1 patent drawingFigure 3

AI summary

A method for analyzing an oligonucleotide, the method including: an application step of applying a sample containing the oligonucleotide and a matrix to a plate; an acquisition step of performing mass spectrometry by irradiating the sample applied to the plate with a laser beam in a MALDI mass spectrometer to acquire a mass spectrum; and a determination step of, when a peak other than a peak derived from the oligonucleotide is observed in the acquired mass spectrum, determining that the sample may contain an impurity, wherein the intensity of the laser beam is an intensity that can suppress in-source decay of the oligonucleotide, and the matrix includes an acetophenone-based compound.